Roche

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Roche and other ETFs, options, and stocks.

About RHHBY

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. 

CEO
Thomas Schinecker
CEOThomas Schinecker
Employees
103,249
Employees103,249
Headquarters
Basel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded
1896
Founded1896
Employees
103,249
Employees103,249

RHHBY Key Statistics

Market cap
349.89B
Market cap349.89B
Price-Earnings ratio
31.58
Price-Earnings ratio31.58
Dividend yield
1.58%
Dividend yield1.58%
Average volume
3.33M
Average volume3.33M
High today
$54.53
High today$54.53
Low today
$50.43
Low today$50.43
Open price
$54.22
Open price$54.22
Volume
139.67K
Volume139.67K
52 Week high
$54.53
52 Week high$54.53
52 Week low
$34.75
52 Week low$34.75

RHHBY News

TipRanks 2d
Roche: Clinical Momentum Improves Outlook but Valuation Keeps Risk/Reward Balanced at Hold

In a report released yesterday, James Quigley from Goldman Sachs upgraded Roche Holding AG to a Hold, with a price target of CHF365.00. Claim 70% Off TipRanks P...

TipRanks 2d
Roche upgraded to Neutral from Sell at Goldman Sachs

Goldman Sachs upgraded Roche (RHHBY) to Neutral from Sell. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news...

TipRanks 2d
Roche upgraded to Neutral at Goldman on improved growth potential

Goldman Sachs upgraded Roche (RHHBY) to Neutral from Sell with a price target of CHF 365, up from CHF 260. The firm cites reduced catalyst risks in 2026 relativ...

Analyst ratings

52%

of 23 ratings
Buy
52.2%
Hold
34.8%
Sell
13%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .